We investigated some functions of monocytes from 20 type Ha hypercholesterolemic (HC) and five homozygons familial hypercholesterolemic (FH) patients. Monocytes from the HC patients contained as much cholesterol and formed as much thromboxane B 2 in response to W-formyl-methionyl-leucylphenylalanine (f MLP) or calcium ionophore A23187 as those from normal individuals. In contrast, the generation of prostaglandin Ej and 6-ketoprostaglandin F l a in response to these agonists was 1.5-3 times normal, and that of leukotriene B 4 was 40-60% of the normal value (p<0.05 for all). Studies in which the combination of fMLP or A23187 with sodium arachldonate were employed suggested that these abnormalities were independent of the availability of the endogenous substrate for the lipoxygenase or cyclooxygenase enzymes. Quantitatively and qualitatively comparable abnormalities were found in monocytes from the five FH patients, and these were little affected when the patients' plasma cholesterol levels were almost normalized by low density lipoprotein apheresis. In keeping with the abnormalities in the eicosanoid metabolism, monocytes from HC patients exhibited a defective ability (p<0.05) to generate O 2~, the extent of which was correlated with the impaired formation of leukotriene B 4 . On the other hand, adhesion studies indicated that patients' cells exhibited an abnormally high ability to adhere to glass (p<0.01). These data indicate the presence of functionally abnormal monocytes in hypercholesterolemia and suggest a direction to be followed to understand the importance of such cells in the premature atherosclerosis that occurs in these patients. 6 -7 It is also known that, when exposed to appropriate stimuli, monocytes/macrophages release cytokines and clotting factors, generate free radicals, and synthesize some metabolites of arachidonic acid, such as prostaglandins (PGs), thromboxane, and chemotactic leukotrienes.
T he accumulation of lipid-laden macrophages in the vasculature is a major event in experimentally induced atherosclerosis.
1 -2 This multistep phenomenon involves the adhesion of circulating monocytes to the intima 3 and their recruitment into the subendothelial space. The latter event occurs in response to locally released chemotactic factors. 4 - 3 It is now established that modified lipoproteins are able to trigger the expression of colony stimulating factors by endothelial cells; this may cause cell migration and proliferation, thus leading to the recruitment of monocytes into the vessel wall. 6 -7 It is also known that, when exposed to appropriate stimuli, monocytes/macrophages release cytokines and clotting factors, generate free radicals, and synthesize some metabolites of arachidonic acid, such as prostaglandins (PGs), thromboxane, and chemotactic leukotrienes. 8 - 11 All these substances are thought to play a direct role in the interaction between monocytes/macrophages and the vasculature.
Familial (FH) and type Ha (HC) hypercholesterolemias are clinical entities marked by an abnormally high tendency toward atherosclerosis and its thrombotic complications. These metabolic disorders are associated with an abnormally low number of low density lipoprotein (LDL) receptors on the surface of monocytes and an abnormally high number of morphologically abnormal monocytes/macrophages in the bloodstream. 12 -13 These data, together with the information that LDL receptors are involved in the in vitro synthesis of arachidonic acid metabolites in resting human bloodderived monocytes, 14 have prompted us to evaluate several ex vivo functions of monocytes from hypercholesterolemic patients. We report here that monocytes from patients with hypercholesterolemia are functionally abnormal, in that they form exceedingly high amounts of PGs and low quantities of leukotriene B 4 (LTB 4 ). In addition, these cells exhibit a higher than normal adhesion to glass and a lower than normal ability to generate the superoxide anion O 2~, the parent compound of oxygenated species with cytotoxic activities. 15 - 16 
Methods

Subjects
Twenty HC patients, five FH patients (three women and two men aged 14-30 years), and 20 normal control subjects matched for sex and age were studied. The clinical and laboratory profiles of the five FH patients, the results of their angiographic studies, the diagnosis of homozygosity, and the details of the LDL apheresis procedure have been previously published. 17 Skin fibroblast cultures, kindly performed by Dr. Joseph L. Goldstein, showed that one patient was receptor-negative, while two were receptor-defective. No other differences were found between these three patients and the other two FH patients (see "Results"). Diagnosis of type Ha hypercholesterolemia in the 20 HC patients was performed according to the World Health Organization criteria. 18 Two of them had signs and symptoms of coronary heart disease; none had symptoms of cerebrovascular or peripheral vascular disease. All FH and HC patients were normotensive, and none had fasting plasma glucose concentrations >95 mg/dL. All patients had been on a lipid-lowering diet (26% fat, 22% protein, and 52% carbohydrates; poh/unsaturated/saturated fat ratio of 0.42) for at least 1 month. Lipid analyses performed by standard methods 19 -21 showed that the mean serum cholesterol level of the five FH patients was 669 ±41.7 mg/dL, that of the 20 HC patients was 370±17.5, and that of the 20 control subjects was 192±10. High density lipoprotein cholesterol of the FH patients was 30.6±4.3 mg/dL, that of the 20 HC patients was 56±3.4, and that of the control subjects was 58.0±4.1. Trigrycerides were 86.2±16.4 mg/dL in the FH patients, 128.9±9.9 in the HC patients, and 88.0±7.9 in the normal subjects. No quantitative or qualitative differences were found between the data obtained using cells from FH or HC patients (p>0.05 for all; see "Results"). Control subjects were selected from the medical staff of the hospital and were on a free-choice diet. At the time of the study, neither patients nor control subjects were taking drugs known to affect plasma lipid levels or white cell function.
Materials
Sterile, pyrogen-free water was used to prepare the reagents and was passed through a 0.2-/Am Millipore filter. Plastic, sterile, disposable tubes, pipettes, Petri dishes (35-mm diameter), syringes, and mouse antihuman monoclonal antibodies to CD3, CD16, CDllc, and CD 14 were from Falcon Labware Division (Becton Dickinson Co., Oxnard, Calif.). Rabbit anti-mouse fluorescein-conjugated antibodies (cod. 23.920.58) were from Janssen (Beerse, Belgium). The eight-chamber tissue-culture slides for the adhesion assay were from Lab-Tek Products (Naperville, 111.). EDTA (Carlo Erba, Milan, Italy) was used as a 100-mM stock solution (pH adjusted to 7.4). Bovine serum albumin (BSA), 5a-cholestane, ferricytochrome c, AMtormyl-methionylleucyl-phenylalanine (fMLP), cytochalasin B, superoxide dismutase (SOD), and zymosan were from Sigma Chemical Co. (St. Louis, Mo.). Culture medium RPMI 1640 (Ca 2+ and Mg* + free) and phosphate-buffered saline (PBS) were from Flow Laboratories (Irvine, Ayrshire, Scotland). The antibiotic-antimycotic mixture contained 10,000 IU/mL penicillin, 10,000 ^ig/mL streptomycin, and 25 ^g/mL fungizone. All these drugs were from GIBCO (Grand Island, N.Y.). Dextran T-500 and Ficoll-Paque were from Pharmacia Fine Chemicals (Uppsala, Sweden). Calcium ionophore A23187 was from Calbiochem, Behring Corp. (La Jolla, Calif.). Ferricytochrome c was dissolved in saline. Stock solutions of A23187 dissolved in ethanol and cytochalasin B were kept at -20°C. fMLP was prepared as a stock solution in dimethyl sulfoxide and stored at -20°C. For the preparation of serum-treated zymosan (STZ), 10 mg/mL of the reagent was resuspended in saline and boiled; after 30 minutes the pellet was washed twice and resuspended in fresh human serum. After an additional 30-minute incubation at 37°C, the sample was centrifuged, the supernatant serum was discarded, and the opsonized zymosan was suspended in saline, divided in aliquots, and kept at -80°C until use. Sodium arachidonate (AASS) was from Nu-Check Prep. (Elysian, Minn. 
Isolation of White Cells
From each subject, 45 mL blood was obtained from the antecubital vein under fasting conditions and placed in a plastic syringe containing 5 mL of 3.8% trisodium citrate. After centrifugation at 150g for 15 minutes at room temperature, the platelet-rich plasma was discarded, and the residual red and white cells were resuspended 1:1 (vol/vol) in PBS. White cells were then isolated by the dextran sedimentation technique. 22 The supernatant was passed on Ficoll-Paque, and monocytes were obtained according to Fisher and Karen 23 as recently described. 17 After hypotonic lysis of red cells, polymorphonuclear cells (PMNs) were isolated by centrifugation and repeated washings. PMNs and monocytes were finally resuspended in PBS containing 0.25% BSA and 0.05% glucose. PMN preparations were >97% pure. The purity of monocyte preparations was >90%, as defined by morphology and esterase staining. 24 In all preparations, cell viability, as determined by the trypan blue exclusion technique, was >95%. Cell counts were performed by phase-contrast microscopy.
Determination of Monocyte Cholesterol Content
To study the cellular cholesterol content, monocytes were isolated as described above, scraped, and collected in 3 mL hexane: isopropyl alcohol (3:2, vol/vol). After a 30-minute incubation, the pellet was discarded, and the organic phase was evaporated under nitrogen. The samples were resuspended in 205 pL hexane; cholesterol esters and free cholesterol were separated by thin-layer chromatography and determined enzymatically by using a commercially available kit (Monotest cholesterol, Boehringer Mannheim, Milan, Italy). In a limited number of subjects, the cholesterol content was also determined by gas chromatography-mass spec-trometry. For these studies (kindly performed by Professor G. Galli, Institute of Pharmacological Sciences, University of Milan, Italy), monocytes were isolated as described above, scraped, and collected in 3 mL PBS. After centrifugation at 700g for 10 minutes, the cells were resuspended in 1 mL PBS, sonicated (20 seconds, pulse 4), and extracted in 5 mL chloroforrn/methanol (2:1, vol/vol) according to Folch et al. 25 Five micrograms of 5a-cholestane was then added as an internal standard; after a 60-minute incubation at 4°C, the organic phase was separated, and samples were dried and resuspended in 500 /xL ION NaOH/6% ethanol. After a further 90-minute incubation at 60°C, 500 fiL distilled water and 1 mL petroleum ether were added, and the organic phase was evaporated under nitrogen, dried, derivatized with a mixture of N-trimethyl silyl-imidazole piperidine (1:1, vol/vol), and analyzed by single-ion mass spectrometry analysis by monitoring ions at mass to charge ratios of 372 and 368. Further details of the mass spectrometric method used have been reported elsewhere. 26 The protein content of each sample was determined by the method of Lowry et al. 27 Eicosanoid Synthesis A 0.5-mL volume of cell suspensions containing 5x10' PMNs or 1x10' monocytes was stirred at 1,000 rpm at 37°C in the presence of CaCl 2 (1 mM). One minute later, the cells were challenged with either 1 /iM fMLP, 1 nM fMLP plus 50 fiM AASS, 10 /iM A23187, or 2 ^M A23187 plus 50 jiM AASS. The incubation was stopped 7 minutes later by adding 2.5 mL methanol; samples were kept at -80°C until assayed. When fMLP was used, cytochalasin B (5 fiM) was added to cell samples 1 minute before adding the agonist. Radioimmunoassay of TxB2 was performed according to Granstrom et al. 28 Fifty percent inhibition of the binding was reached at 85 pg TxBj. PGE? and 6-keto-PGF la were determined by using an enzyme-linked immunoassay system (Cayman) according to the manufacturer's recommendations. LTB 4 levels in white cell supematants were determined by a radioimmunoassay using a commercially available kit (Amersham, Amity PG, Milan, Italy). This assay has been validated for the measurement of metabolite levels by comparison with reversedphase high-pressure liquid chromatography. 29 
Superoxide Anion (O 2~) Generation
Generation of O 2~ by monocytes was monitored at 37°C at 550 and 468 run in a dual-beam spectrophotometer (Shimadzu, Kyoto, Japan) by measuring the SODinhibitable reduction of cytochrome c according to Babior et al. 30 Details of the method used have been recently reported. 29 Briefly, 1 mL of the cell suspensions (3X10 5 PMNs or 1.5 xlO 5 monocytes) was incubated with 1 mM CaCl 2 , 1 mg/mL ferricytochrome c, and either 1 mg/mL zymosan; 1 /AM fMLP; 1 jiM fMLP plus 50 fiM AASS; 10 /xM A23187; or 2 /xM A23187 plus 50 yM AASS. When fMLP was used, cytochalasin B (5 /iM) was added to cell samples 1 minute before adding the agonist. After a 30 -minute incubation at 37°C with gentle stirring, the reaction was stopped in an ice bath, the vials were centrifuged for 2 minutes at 12,000g, and the absorbance was determined. The results were expressed as nanomoles O 2~ per 10 6 cells per 30 minutes, and a millimolar extinction coefficient of 24.5 tween the oxidized and the reduced forms of cytochrome c. In each case, the amounts of reduced cytochrome c in the presence of 30 fig/mL SOD were subtracted from the total.
Adherence Assay
Monocyte adherence to glass was assessed by the method of Shellito and Murphy. 31 For this assay, 0.3 mL mononuclear cells resuspended in RPMI 1640 containing penicillin, streptomycin, fungizone, and 10% autologous serum were placed on eight-chamber tissueculture slides. After 15 minutes at 37°C in a 5% CO 2 atmosphere, the chambers were rinsed three times with PBS, air-dried, and stained with the May-GriinwaldGiemsa reagent. Monocyte counts were performed by microscopy, and the results were expressed as mean±SEM of adherent monocytes per 100 total cells in five high-power fields (x 1,000). In some experiments the effect of LTB 4 on monocyte adhesion was determined by performing the studies in the presence of 24 fiL of a 1:5,000 solution of a monospecific anti-LTB 4 antibody. At these concentrations, the antibody bound approximately 8 pg LTB 4 .
Fluorescence-Activated Cell-Sorter (FACS) Studies
For these studies, lxlO 6 freshly isolated mononuclear cells (from the five FH and two HC patients and from 10 control subjects) were resuspended in 20 [iL buffer and incubated for 30 minutes at 4°C with 1.25 mg/mL of human immunoglobulin G (to saturate the immunoglobulin G Fc receptor) and 20 /iL of the anti-CDllc, -CD3, -CD14, and -CD16 antibodies. The cells were then washed twice with cold PBS containing 2% BSA and 0.02% NaN 3 and analyzed in a Becton Dickinson FACS scanner. For studies with the nonphycoerythrin-conjugated antibody anti-CDllc, the immune complex was further incubated at 4°C for 30 minutes with a rabbit anti-mouse fluorescein-conjugated antibody and washed twice in PBS-BSA at 4°C. The cells were then resuspended at 10 6 /mL in PBS containing 0.013 M EDTA and analyzed. In each case and for each subject, forward or low-angle scatter, right-angle scatter, and fluorescence at 90° were determined.
Statistical Analysis
Values are expressed as mean±l SEM. Student's t test for paired and grouped data was used when appropriate. Linear regression was performed according to standard procedures.
Results
Studies on Cells From FH Patients
FACS analysis showed that the preparations of mononuclear cells from the five FH patients were comparable with those from the control subjects with respect to size and a variety of cell-surface antigens (CDllc, CD3, CD14, and CD16). In addition, these studies confirmed the presence of a discrete number of abnormal mononuclear cells circulating in the bloodstream of the FH patients. 13 In samples obtained on two different occasions, it was observed that after exposure to 1 /iM fMLP or 10 fiM A23187, monocytes from the five FH patients ; FH, familial hypercholesterolemia; control, control subjects; fMLP, N-formylmethionyl-leucyl-phenylalanine. A 0.5-mL volume of cell suspensions containing 1x10' monocytes was challenged with 1 fiM fMLP or 10 ^M A23187. Triplicate determinations of LTB 4 and TXB2 were performed as detailed in "Methods."
Values are the mean±l SEM of the individual data of five patients and five control subjects.
•p<0.02 control vs. FH. generated normal amounts of TxB?, whereas they formed significantly (p<0.02) less LTB 4 than those from the control group (Table 1) . The impaired leukotriene formation appeared to be little affected (p>0.05) by LDL apheresis, preapheresis data being similar to those obtained 2 days after the procedure. Likewise, thromboxane generation by monocytes was unaffected by apheresis (data not shown). During this time, plasma cholesterol levels were almost within normal limits.' 7 The generation of eicosanoids by monocytes in hypercholesterolemia was further evaluated.
Eicosanoid Synthesis in Monocytes and PMNs From HC Patients
Like the cells from the FH patients, mononuclear preparations from the HC patients evaluated were entirely comparable with those from control subjects with respect to the cell-surface antigens reported above. In addition, TxB? formation in response to fMLP alone or in combination with AASS was quantitatively comparable in cells from HC patients and control subjects (Figure 1, panels b and d) . Furthermore, after stimulation with fMLP, monocytes from type Ha patients formed significantly lower amounts of LTB 4 than those from control subjects (Figure 1, panel a) . The impaired synthesis of LTB 4 was also observed when monocytes were incubated with A23187. After exposure to a combination of AASS and fMLP, monocytes from control subjects formed three-to fourfold as much LTB 4 as in response to fMLP alone (1.9±0.6 ng/2xlO 6 monocytes when fMLP was used alone versus 6.6±1.9 when it was used in combination with AASS; p<0.001) (Figure 1 , panels a and c). A similar enhancement was also observed in cells from type Ha patients. However, the difference in the formation of LTB 4 by monocytes from control subjects and HC patients exposed to single agents could also be detected in response to both agents ( Figure 1, panel c) . The possibility that, in addition to leukotriene synthesis, the formation of other eicosanoids was quantitatively abnormal in the patients' monocytes, was then addressed. As shown in Table 2 , this appeared to be the case. The HC patients' cells formed statistically significantly higher amounts of PGEj and 6-keto-PGF la in response to A23187 alone than cells from control subjects. Quantitatively and qualitatively similar results were obtained when monocytes from the five FH patients were used. In an attempt to clarify the mechanism(s) of the abnormalities observed, the following parameters were checked. The possibility of an exceedingly high cholesterol content of PGE2, prostaglandin E 2 ; 6-keto-PGF la , 6-ketoprostaglandin F lCT ; HC, type Ila hypercholesterolemia; control, control subjects; AASS, sodium arachidonate. A 0.5-mL volume of patients' or control subjects' cell suspensions containing 1 xlO 6 monocytes was challenged with 2 /iM A23187 alone or in combination with 50 jtM AASS. Triplicate determinations of PGE2 and 6-keto-PGF la were performed as detailed in "Methods."
FIGURE 1. Bar graphs showing leukotriene B 4 (LTB 4 ) and thromboxane B 2 (TxB 2 ) generation by isolated monocytes of 20 control (hatched bars) and 20 type Ha hypercholesterolemic (open bars) subjects stimulated with 10~6 M N-formylmethionyl-leucyl-phenylalanine (fMLP) or 10 /JLM A23187 (panels a and b) and 10~* M fMLP or 2 \iM A23187 plus 50 fiM sodium arachidonate (AASS) (panels c and d
•p<0.01 control vs. HC. None of these differences were significant (p>0.05). The absolute cholesterol level of monocytes was rather low in these studies and, at least in some cases, was difficult to determine with the enzymatic method. Thus, the possibility that the normal cholesterol content of the patients' monocytes might be due to the analytical procedure used was taken into consideration. In view of this, in seven HC patients (plasma cholesterol, 326±43 mg/dL; plasma triglycerides, 126±27 mg/dL) and in five normal subjects (plasma cholesterol, 177±47 mg/dL; plasma triglycerides, 114 ±43 mg/dL) quantitative determinations of monocyte cholesterol content were performed by gas chromatography-mass spectrometry. Despite the statistically significant (p<0.01) difference in plasma cholesterol, monocyte cholesterol content was similar in the two settings: 38.1±8 fig/tng protein in cells from control subjects and 42.5±11.8 in those from patients (p>0.05).
The possibility that white cells other than monocytes might exhibit abnormalities in the leukotriene generation was then explored. For these purposes, LTB 4 synthesis was measured in suspensions of PMNs exposed to the combination of either A23187 plus AASS or fMLP plus AASS. The formation of LTB 4 by the patients' PMNs was normal (Table 3) .
Superoxide Anion Generation
Like the formation of LTB 4 , normal amounts of O 2w ere generated by suspensions of PMNs exposed to either A23187 plus AASS or fMLP plus AASS (Table  3) . Normal amounts of O 2~ were also found when PMNs were incubated with single agents: 1 mg/mL opsonized zymosan (60.1 ±5.6 nmol/10 6 in PMNs from control subjects and 54.5±4.1 in cells from patients; />>0.05); A23187 (8.9±1.1 nmol/10 6 in PMNs from control subjects and 8.4±0.8 in those from patients; p>0.05); and fMLP (63.1 ±6.4 nmol/10 6 in PMNs from control subjects and 52.6±4.6 in those from patients; p>0.05). On the other hand, parallel to the impaired synthesis of LTB 4 , abnormally low amounts of O 2~ were generated by the monocytes of type Ila patients exposed to fMLP or A23187 (Figure 2 ). The addition of AASS to either stimulus markedly increased the generation of O 2~ by monocytes of control subjects and patients (p<0.01). However, the formation of the free radical by the cells of the patients was always lower than that of control subjects ( Figure 2 ). In addition, a defective (approximately 30%) generation of O 2~ was also observed when 16 Regardless of the LDL apheresis, qualitatively and quantitatively similar abnormalities were found in monocytes from FH patients exposed to fMLP, A23187, or STZ. Regression analysis showed a correlation between the defective generation of O 2~ and the formation of LTB 4 by monocytes exposed to fMLP plus AASS (r=0.73,/><0.01). A similar relation was found when the data obtained in response to A23187 plus AASS were analyzed.
Monocyte Adherence to Glass
The possibility of functionally abnormal monocytes in hypercholesterolemia was further explored by evaluating the adhesion of the cells to glass. Under our experimental conditions, the adherence of monocytes from HC patients per 100 total cells in five high-power fields was 76.7±4.4%. When the cells from control subjects were used, the adherence was 52.8±4.4%. The latter figure was little affected by preincubating the samples with a monospecific antibody against LTB 4 . In five such experiments, pretreatment with the antibody reduced monocyte adhesion by only 3-5% (/>>0.05). The difference in the adhesive ability of monocytes from the control subjects and from the patients was highly significant (p<0.001).
Discussion
Some years ago we observed a discrete number of morphologically abnormal monocytes/macrophages in the bloodstream of FH patients. 13 Recent in vitro reports have clarified that LDL receptors are involved in the synthesis of arachidonic acid metabolites in resting human blood-derived monocytes.
14 Together, these findings prompted us to evaluate the ex vivo synthesis of eicosanoids in leukocytes from hypercholesterolemic patients. In agreement with the data by Croft et al, 32 PMNs from our type Ha patients synthesized as much Txl$2 and LTB 4 as the cells from control subjects. In contrast, an abnormality in the formation of eicosanoids by monocytes was found, as these cells produced abnormally low amounts of LTB 4 ( Figure 1 ) and 1.5-3 times as much PGE2 and 6-keto-PGFl CT as those from control subjects. The data make it unlikely that the reduced capacity of monocytes from hypercholesterolemic subjects to generate LTB 4 depends on changes in the activity of phospholipase enzymes. Monocytes from HC patients formed as much TxB? and higher than normal amounts of PGE? and 6-ket0-PGF lo . In addition, studies with the combination of agents were consistent with the possibility that the abnormality was independent of the availability of the substrate for the cyclooxygenase or 5-lipoxygenase enzymes. Salbach et al 14 have also studied the ability of monocytes to form cyclooxygenase and lipoxygenase metabolites. In agreement with our findings, they also reported a discrepancy in the ability of normal monocytes to form cyclooxygenase and lipoxygenase metabolites after in vitro incubation of normal monocytes with reconstituted LDL containing cholesteryl [l-
14 C]arachidonate. Salbach et al interpreted their finding as an indication that, in vitro, the LDL-receptor pathway preferentially promotes the synthesis of PGH synthase products in resting human blood-derived monocytes. For our studies, we used monocytes from patients with abnormalities of the classical LDL-receptor pathway. However, our data cannot rule out the possibility that the LDL receptor is involved in several monocyte functions. Monocytes from FH and HC patients behaved as a homogeneous population. Abnormalities comparable with the ones that we observed in our patients have been reported using monocytes from rabbits fed a hypercholesterolemic diet. 33 Monocyte cholesterol determinations make it unlikely that the abnormalities observed in our patients were related to an abnormally high cholesterol ester content of patients' monocytes. Likewise, a defective production of LTB 4 and a normal formation of TXB2 were also present in monocytes from FH patients at a time when plasma levels of cholesterol were almost normal (2 days after LDL apheresis). Modified lipoproteins, such as the ones studied by Salbach et al, 14 are known to cause a series of as yet poorly clarified effects on monocytes.
LTB 4 is a weak agonist for the generation of O 2~ by monocytes. In addition to abnormalities in the production of eicosanoids, mononuclear cells from rabbits fed a hypercholesterolemic diet show abnormalities in the formation of this free radical. 33 Therefore, we evaluated whether the impaired formation of LTB 4 was associated with a defective generation of O 2~ by monocytes. The data showed that this was the case. In parallel with the reduction of LTB 4 , monocytes from type Ila patients formed abnormally low amounts of the superoxide anion. The possibility of a correlation between the two defects was further suggested by the observation of a significant correlation between LTR, and O 2~ generation by monocytes. On the other hand, the defective capacity to form oxygenated species was detected after the exposure of monocytes to the combination of AASS with soluble stimuli. There may be functional abnormalities of reduced nicotinamide adenine dinucleotide phosphate oxidase and/or SOD enzymes to explain the defective free-radical generation observed in patients' monocytes.
The adhesive properties of monocytes are thought to play a central role in the involvement of these cells in atherosclerosis. 5 Therefore, we explored the adhesion to glass of monocytes from these patients and found that it was higher than normal. This difference cannot be attributed to differences in the relative number of monocytes present in the cell preparations used. Mononuclear cell samples of patients and control subjects contained almost the same number of monocytes (as assessed by a-naphthyl acetate esterase). In addition, FACS analysis indicated that mononuclear cell preparations from some of the patients were comparable to those from control subjects with respect to several surface-associated antigens. Several lipoproteins, including the ones that are abnormally high in hypercholesterolemia, are known to cause functional changes in the adhesive capacities of monocytes. Our data show functional abnormalities in the ability of monocytes from hypercholesterolemic subjects to form leukotrienes and to generate superoxide anion. They also document that the adhesive ability of these cells as well as the formation of some prostaglandins is abnormally high. Presently, the mechanisms leading to these abnormalities are little understood. Likewise, whether the impaired capacity of monocytes from hypercholesterolemic subjects to synthesize LTB 4 and radicals with cytotoxic activities is a mechanism of protection of the vasculature in hypercholesterolemia remains to be established. We believe that this is a direction to be followed to understand the importance of lipoproteins and monocytes in the premature atherosclerosis of these patients.
